Sarepta Therapeutics
SRPT
SRPT
128 hedge funds and large institutions have $794M invested in Sarepta Therapeutics in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 45 increasing their positions, 41 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% less call options, than puts
Call options by funds: $51.2M | Put options by funds: $65.6M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
128
Holding in Top 10
1
Calls
$51.2M
Puts
$65.6M
Top Buyers
| 1 | +$20.1M | |
| 2 | +$19.5M | |
| 3 | +$5.96M | |
| 4 |
Millennium Management
New York
|
+$5.85M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.29M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$9.55M | |
| 3 | -$8.05M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$6.71M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$6.2M |